In Chevron's Fall, Attys See Conflicting Rulings, Circuit Splits
By Dan McKay · July 16, 2024, 5:05 PM EDT
The end of Chevron deference, along with other U.S. Supreme Court decisions weakening the authority of federal agencies, may make the drug regulatory landscape more volatile — not less — as...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login